TCM
TCG Crossover Management’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-663,610
| Closed | -$16.9M | – | 23 |
|
|
2023
Q1 | $16.9M | Sell |
663,610
-320,000
| -33% | -$8.14M | 3.29% | 13 |
|
|
2022
Q4 | $28.7M | Sell |
983,610
-180,390
| -15% | -$5.27M | 5.07% | 8 |
|
|
2022
Q3 | $23.9M | Sell |
1,164,000
-150,000
| -11% | -$3.08M | 7.16% | 4 |
|
|
2022
Q2 | $15.2M | Hold |
1,314,000
| – | – | 6.46% | 7 |
|
|
2022
Q1 | $24.3M | Hold |
1,314,000
| – | – | 9.75% | 2 |
|
|
2021
Q4 | $26M | Buy |
+1,314,000
| New | +$26M | 12.16% | 2 |
|